Sovereign Nations. Different Laws. One Complicated Payments System.
Sovereign Nations. Different Laws. One Complicated Payments System. On Indigenous Peoples' Day, it's time to examine why tribal gaming, ...
With Prime Minister Justin Trudeau’s departure on the horizon, Canada’s cannabis industry is facing a pivotal moment. His decision to legalize recreational cannabis in 2018 reshaped the country’s economy and social policies, making Canada the only G7 nation to federally legalize both medical and adult-use cannabis.
The policy’s success is evident: recent polls show 61% of Canadians support cannabis legalization, solidifying its place as one of Trudeau’s most recognized achievements. According to a survey by Leger, Canadians rank legalization among his most significant accomplishments. Beyond public perception, the industry has contributed billions to the Canadian economy, creating jobs, driving investment, and positioning the country as a global leader in cannabis innovation and regulation.
Despite public support, the industry faces uncertainty. A potential Conservative Party government led by Pierre Poilievre could take a different approach, raising concerns about the future of cannabis regulation.
One area of speculation is the potential downsizing of Health Canada’s Controlled Substances and Cannabis Branch, which employs over 200 staff members to regulate the industry. While the Conservative Party has not explicitly stated plans to cut funding for cannabis oversight, their general stance on cost-cutting measures raises concerns among industry stakeholders. A reduction in oversight could lead to delays in licensing, amendments, and export approvals, potentially slowing the growth of new businesses and discouraging international partnerships.
The regulatory future of CBD is another area of concern. Health Canada has long discussed expanding CBD sales into pharmacies, health food stores, and other mainstream retail outlets, but a shift in government priorities could stall progress.
Marketing restrictions and THC limits on edibles also remain contentious. Without reforms, licensed producers will struggle to compete with illicit operators and global competitors. If the Liberal government doesn’t push key reforms forward now, a new administration may deprioritize or delay much-needed industry improvements, leaving businesses unable to innovate or expand into new markets.
Canada’s cannabis sector has grown into a multibillion-dollar industry, creating thousands of jobs and generating substantial tax revenue. Any rollback or stagnation in policy could put these economic gains at risk, limit patient access, and weaken Canada’s position as a global cannabis leader.
A lack of regulatory progress could also impact international trade opportunities. With countries like Germany moving toward legalization, Canada has the chance to establish itself as a major exporter of cannabis products. However, if the government fails to streamline regulations and reduce industry burdens, Canadian producers may lose ground to emerging competitors in Europe, Latin America, and the United States.
If progress stalls, Canada may go from a trailblazer in cannabis legalization to a cautionary tale about the consequences of incomplete reform.
Given the uncertainty ahead, industry leaders must take an active role in shaping the future. This means:
Legalization is not a one-time event—it’s an ongoing process requiring adaptation and improvement. As Trudeau’s tenure ends, the Canadian cannabis industry must ensure future governments build on the progress made rather than let it stagnate.
By staying engaged, advocating for responsible policies, and demonstrating the industry’s economic value, Canada can maintain its standing as a leader in cannabis regulation and innovation. The industry must remain proactive, ensuring that the foundation Trudeau helped build is not only preserved but strengthened for future growth.
